AN ACTION-PACKED week on Wall Street ends with a bang as index-tracking funds are set to reshuffle US$250 billion of shares, ...
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...
General Motors has recalled nearly 450,000 vehicles equipped with indicators which don't promptly warn drivers when brake fluid levels are too low.